DRKS00016632已完成不适用
Post-market surveillance study to evaluate tolerability, acceptance, improvement in quality of life and the course of symptoms in patients suffering from an acute uncomplicated urinary tract infection and receiving supportive treatment with Femannose®
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 103
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- Female
入选标准
- •Signed informed consent (data protection)
- •- Female outpatients aged =18 years with acute uncomplicated urinary tract infection
排除标准
- •- Patients <18 years (children and adolescents)
- •- Patients with contraindications according to user manual:
- •- known hypersensitivity to D-mannose or to any of the other ingredients of Femannose® N
研究者
相似试验
已完成
4 期
A study of Pregabalin IP 75 mg and Nortriptyline 10 mg Tablets in patients with diabetic peripheral neuropathyCTRI/2022/02/040438Micro Labs Limited203
招募中
4 期
A Post-Marketing Surveillance Study to assess the safety and efficacy of Cetuximab plus Radiotherapy (RT) in Locally Advanced Squamous Cell Carcinoma of Head & Neck (LA SCCHN)CTRI/2011/091/000206Merck Specialities Pvt Ltd200
尚未招募
4 期
A post-marketing surveillance for the Evaluation of the safety of TGlobulin25 for the induction of immunosuppressive therapy in adult kidney transplant candidatesIRCT20201230049888N1Kawsar biotech company100
尚未招募
4 期
Post marketing surveillance study of Pitavastatin for evaluation of its safety and efficacy in patients with diabetes and high cholesterolCTRI/2013/05/003686Cadila Healthcare500
已完成
4 期
Post-marketing SurveillanceStudy in patients prescribed with Darbepoetin alfaCTRI/2017/04/008338Hetero Drugs Limited503